Plethysmographic effects of doxazosin in essential hypertensive patients

J Hypertens Suppl. 1989 Dec;7(6):S290-1. doi: 10.1097/00004872-198900076-00141.

Abstract

In the treatment of hypertensive patients with peripheral vascular disease, alpha 1-adrenoceptor blockers may be considered first-choice drugs since they reduce the total peripheral resistance and do not decrease the plasma volume. As a preliminary step, we investigated the plethysmographic effects of doxazosin (1-8 mg for 6 weeks) on calf flow in 32 uncomplicated hypertensive patients. Despite the fall in sitting and standing blood pressure (from 163 +/- 18/101 +/- 6 to 147 +/- 19/94 +/- 8 mmHg and from 162 +/- 18/107 +/- 9 to 145 +/- 18/95 +/- 8 mmHg, respectively; both P less than 0.001) the calf flow was not decreased at rest and after ischaemia. Resting resistance was not significantly reduced (from 49.5 +/- 35 to 38.9 +/- 33 mmHg/100 ml per min) but its fall was significantly correlated with the fall in mean blood pressure (rs = 0.35, P less than 0.05). These findings confirm that doxazosin may be useful in the treatment of hypertension complicated by peripheral artery disease.

MeSH terms

  • Adrenergic alpha-Antagonists / therapeutic use*
  • Adult
  • Aged
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Doxazosin
  • Drug Evaluation
  • Female
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / physiopathology
  • Leg / blood supply
  • Male
  • Middle Aged
  • Plethysmography
  • Prazosin / analogs & derivatives*
  • Prazosin / therapeutic use
  • Regional Blood Flow / drug effects
  • Regional Blood Flow / physiology

Substances

  • Adrenergic alpha-Antagonists
  • Antihypertensive Agents
  • Doxazosin
  • Prazosin